Stay updated on PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T20:44:29.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the outcomes of advanced hepatocellular carcinoma (HCC) patients treated with anti PD-1 inhibitors in combination with incomplete thermal ablation.
    Difference
    0.1%
    Check dated 2024-06-06T14:16:59.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for patients with advanced hepatocellular carcinoma (HCC), specifying inclusion and exclusion criteria based on health conditions and prior treatments.
    Difference
    14%
    Check dated 2024-05-22T20:33:27.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention being discussed. This change may be related to medical and healthcare-related publications and documentation.
    Difference
    1%
    Check dated 2024-05-01T18:31:29.000Z thumbnail image

Stay in the know with updates to PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.